Comparative statistics by cancer registry
Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
(Barshi, India, 1993-2000 cases followed-up until 2003)Click on cancer site (ICD-10 code) for comparison
| Site | ICD-10 | No. of cases | Male | Female | Number of cases by age group | Relative survival by age group | ||||||||||||
| 5-year survival | 5-year survival | |||||||||||||||||
| No. | Abs | Rel | No. | Abs | Rel | <45 | 45-54 | 55-64 | 65-74 | 75+ | <45 | 45-54 | 55-64 | 65-74 | 75+ | |||
| C01-02 | Tongue | 47 | 33 | 3.0 | 3.7 | 14 | 21.4 | 23.4 | 7 | 6 | 18 | 15 | 1 | 14.5 | 17.5 | 13.1 | 0.0 | 0.0 |
| C03-06 | Oral cavity | 55 | 35 | 20.1 | 22.0 | 20 | 24.2 | 26.1 | 17 | 13 | 11 | 10 | 4 | 28.2 | 22.0 | 51.0 | 0.0 | 0.0 |
| C12-13 | Hypopharynx | 80 | 71 | 9.7 | 13.0 | 9 | 9 | 8 | 22 | 31 | 10 | 11.4 | 13.2 | 5.3 | 13.8 | 19.4 | ||
| C15 | Oesophagus | 97 | 57 | 40 | 10.0 | 12.8 | 7 | 16 | 32 | 32 | 10 | 0.0 | 6.6 | 0.0 | 8.7 | 0.0 | ||
| C16 | Stomach | 45 | 28 | 17 | 11.8 | 16.0 | 8 | 7 | 14 | 13 | 3 | 0.0 | 0.0 | 0.0 | 11.6 | 0.0 | ||
| C19-20 | Rectum | 49 | 32 | 9.5 | 11.3 | 17 | 14.1 | 15.7 | 14 | 10 | 10 | 11 | 4 | 0.0 | 42.8 | 0.0 | 21.8 | 0.0 |
| C22 | Liver | 47 | 44 | 3 | 2 | 10 | 18 | 11 | 6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||||
| C32 | Larynx | 33 | 28 | 15.1 | 19.0 | 5 | 7 | 5 | 6 | 9 | 6 | 29.4 | 29.9 | 0.0 | 16.4 | 0.0 | ||
| C33-34 | Lung | 47 | 31 | 3.6 | 3.9 | 16 | 8 | 10 | 10 | 12 | 7 | 15.3 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| C44 | Other skin | 39 | 23 | 60.9 | 80.7 | 16 | 72.3 | 88.7 | 5 | 5 | 13 | 11 | 5 | 40.8 | 84.6 | 78.7 | 91.7 | 116.7 |
| C50 | Breast | 124 | 3 | 33.3 | 50.4 | 121 | 49.6 | 55.4 | 26 | 42 | 29 | 22 | 5 | 42.4 | 61.3 | 40.3 | 75.1 | 116.7 |
| C53 | Cervix | 406 | 406 | 32.2 | 35.1 | 109 | 106 | 115 | 67 | 9 | 37.9 | 37.0 | 40.4 | 19.7 | 0.0 | |||
| C60 | Penis | 43 | 43 | 44.7 | 58.7 | 8 | 3 | 10 | 16 | 6 | 51.2 | 106.3 | 46.0 | 62.8 | 64.3 | |||
| C82-85+C96 | Non-Hodgkin lymphoma | 36 | 26 | 17.9 | 20.8 | 10 | 30.0 | 33.0 | 14 | 7 | 8 | 7 | 0 | 29.1 | 0.0 | 42.0 | 13.4 | 0.0 |
| C92-94 | Myeloid leukaemia | 40 | 28 | 12.9 | 14.0 | 12 | 16.7 | 17.2 | 23 | 10 | 3 | 4 | 0 | 12.3 | 7.1 | 79.8 | 0.0 | 0.0 |
Graphs:
Other tables available for this registry:
| - Table1: | Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Barshi, India, 1993-2000 cases followed-up until 2003) |
| - Table2a: | Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Barshi, India, 1993-2000 cases followed-up until 2003) |
| - Table3: | Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Barshi, India, 1993-2000 cases followed-up until 2003) |
| - Table4: | Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Barshi, India, 1993-2000 cases followed-up until 2003) |
| - Table5: | Comparison of 5-year absolute and relative survival of cases diagnosed between 1988-1992 and 1993-2000 (Barshi, India) |
Registry chapter:
 | Consult the chapter in Cancer survival in developping countries (Volume II) |